The findings are consistent with previous research indicating that GDNF and miRNA-29a may be involved in neuronal plasticity, suggesting that further research on their effects on neuronal functioning may lead to the development of novel therapeutic strategies for cognitive disorders in psychosis. The gene discussed is GDNF; the disease is Cognitive impairment.